BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skowronek J, Zwierzchowski G. Brachytherapy in the treatment of bile duct cancer - a tough challenge. J Contemp Brachytherapy. 2017;9:187-195. [PMID: 28533809 DOI: 10.5114/jcb.2017.66893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Buerlein RCD, Wang AY. Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma.Gastrointest Endosc Clin N Am. 2019;29:351-367. [PMID: 30846158 DOI: 10.1016/j.giec.2018.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Khosla D, Zaheer S, Gupta R, Madan R, Goyal S, Kumar N, Kapoor R. Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review. World J Gastrointest Endosc 2022; 14(3): 106-112 [DOI: 10.4253/wjge.v14.i3.106] [Reference Citation Analysis]
3 Fernandez C, Croke J, Alfieri J, Golden DW. A guide to curriculum inquiry for brachytherapy simulation-based medical education. Brachytherapy 2020:S1538-4721(20)30173-2. [PMID: 34756355 DOI: 10.1016/j.brachy.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Skowronek J. Current status of brachytherapy in cancer treatment - short overview. J Contemp Brachytherapy 2017;9:581-9. [PMID: 29441104 DOI: 10.5114/jcb.2017.72607] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
5 Gkika E, Hawkins MA, Grosu AL, Brunner TB. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Front Oncol 2020;10:604387. [PMID: 33381458 DOI: 10.3389/fonc.2020.604387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liao CH, Liu Y, Wu YF, Zhu SW, Cai RY, Zhou L, Yin XM. microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3. J Cell Physiol 2019;234:17786-99. [PMID: 30887508 DOI: 10.1002/jcp.28404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Deufel CL, Furutani KM, Dahl RA, Grams MP, McLemore LB, Hallemeier CL, Neben-Wittich M, Martenson JA, Haddock MG. Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter. Brachytherapy. 2018;17:718-725. [PMID: 29776892 DOI: 10.1016/j.brachy.2018.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Lancellotta V, Kovács G, Tagliaferri L, Perrucci E, Colloca G, Valentini V, Aristei C. Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer. Biomed Res Int 2018;2018:2178469. [PMID: 29581964 DOI: 10.1155/2018/2178469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
9 John ES, Tarnasky PR, Kedia P. Ablative therapies of the biliary tree. Transl Gastroenterol Hepatol 2021;6:63. [PMID: 34805585 DOI: 10.21037/tgh.2020.02.03] [Reference Citation Analysis]
10 Tantau AI, Mandrutiu A, Pop A, Zaharie RD, Crisan D, Preda CM, Tantau M, Mercea V. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies. World J Hepatol 2021; 13(2): 166-186 [PMID: 33708349 DOI: 10.4254/wjh.v13.i2.166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]